WHAT IS SKYRIZI?

Meet SKYRIZI - the First IL-23 Specific Inhibitor for Crohn's

SKYRIZI is a prescription medication for adults with moderate to severe Crohn’s disease.

It's the first treatment for Crohn's that specifically targets the interleukin-23 (IL-23) protein, which is one of the key proteins responsible for inflammation. By targeting IL-23, SKYRIZI helps reduce this excess inflammation that can contribute to Crohn's symptoms.

ABOUT SKYRIZI

TAKING SKYRIZI

ASKING ABOUT SKYRIZI

Discover More About SKYRIZI

Use this patient brochure to get information to help you talk to your doctor about Crohn’s—and learn how SKYRIZI can help.